J&J Taps Aspect Biosystem's 3D Printing Tech For Meniscus Implant
Executive Summary
3D bioprinting and tissue engineering specialist Aspect Biosystems has entered a research collaboration with Johnson & Johnson's DePuy Synthes to create bioprinted knee meniscus tissue suitable for surgical therapy. It is one of more than 50 commercial and academic partnerships J&J has entered to develop complementary technologies and materials for its medical devices.
You may also be interested in...
Novo Nordisk Teams With Aspect Biosystems On Diabetes Cell Therapy
Aspect says its bioprinted tissue therapeutics include immune-resistant encapsulation, which Novo Nordisk hopes will offer a safer approach to type 1 diabetes cell therapy.
DePuy Synthes Builds Out Trauma Offering With TRS' 3D-Printed Tech
Underlining its focus on 3D-printing and the potential this technology can bring, DePuy Synthes has acquired the 3D-printed scaffold platform of Tissue Regeneration Systems, enabling the orthopedics leader to develop patient-specific trauma products in-house.
J&J Announces New Device Collaborations
The Johnson & Johnson Innovation Center projects include a focus on solid-tumor resections, knee replacement procedures and atrial fibrillation ablation – as well as tracking down biomarkers tied to diabetes and prostate cancer.